// App-Quantinova.ai

3329 : Changes of ADAMTS13 Activity and VWF Level in the Plasma of Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)

Researchers

Presenter

  • Luping Hu

Principal Investigators

  • Qian Zhu

  • Changgeng Ruan

  • Wu Depei

  • Yang Xu

  • Xiaohui Hu

  • Jian Su

  • Zhenni Ma

  • Wei Zhang

  • Aining Sun

  • Huiying Qiu

  • Zhaoyue Wang

Medical Centers

  • Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China

  • Thrombosis and Hemostasis Key Lab of the Ministry of Health, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou, China

  • Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China

  • Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China

  • Hematology, The First Affiliated Hosp. of Soochow Univ., Jiangsu Inst. of Hematology, Suzhou, China

  • Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First affiliated Hospital, Soochow University, Suzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Graft-versus-host disease

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim